Title:
PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYNIONE AND DEXTROMETHORPHAN AND APPLICATION THEREOF IN TREATING PULMONARY FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2022/253353
Kind Code:
A1
Abstract:
Disclosed in the present invention are a pharmaceutical composition or pharmaceutical kit comprising hydroxynione or a pharmaceutically acceptable salt thereof and dextromethorphan or a pharmaceutically acceptable salt thereof, and an application thereof in treating pulmonary fibrosis. The hydroxynione or the pharmaceutically acceptable salt thereof and the dextromethorphan or the pharmaceutically acceptable salt thereof, when used in combination, have excellent effects in lung function repair, pulmonary fibrosis inflammation inhibition and pulmonary fibrosis symptom improvement, and therefore, can be used as drugs for treating or alleviating pulmonary fibrosis or improving pulmonary fibrosis symptoms.
Inventors:
LUO YING (CN)
MA SONGJIANG (CN)
MA SONGJIANG (CN)
Application Number:
PCT/CN2022/097197
Publication Date:
December 08, 2022
Filing Date:
June 06, 2022
Export Citation:
Assignee:
BEIJING CONTINENT PHARMACEUTICALS CO LTD (CN)
International Classes:
A61K31/485; A61K31/4418; A61P11/00
Foreign References:
| CN112823795A | 2021-05-21 | |||
| US20080161361A1 | 2008-07-03 |
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: